HER2-PositiveRecurrent or Metastatic Breast Cancer
1 clinical trials · Condition
◉ Watch HER2-PositiveRecurrent or Metastatic Breast Cancer
| Record | Firm | Date |
|---|---|---|
| A Phase III Study of SHR-A1811 Injection With or Without Pertuzumab in HER2-Positive Recurrent or Metastatic Breast Cancer (NCT06057610) | Jiangsu HengRui Medicine Co., Ltd. | 2023-10-16 |
Track HER2-PositiveRecurrent or Metastatic Breast Cancer automatically
Every clearance here is in the API, with alerts when new ones post.